Oncolytics Biotech ( ($ONCY) ) has shared an update. On October 10, 2025, Oncolytics Biotech Inc. submitted a corporate presentation to the ...

Sarepta Therapeutics is showing signs of recovery, driven by its robust pipeline and recent revenue growth, despite past ...

There are a lot of hot sapphic celebs out there, so we'll have to do a thorough investigation to make a decision!

Ratings for Stoke Therapeutics (NASDAQ: STOK) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ...

This important study presents convincing findings on creating an exhaustive library of new enhancer-AAVs targeting astrocytes and oligodendrocytes with high potential for both basic and translational ...